Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Computational Drug Repurposing for All Epidermolysis Bullosa Simplex (EBS) Cases

NCT03269474 is registered in ClinicalTrials.gov with Joyce Teng as lead sponsor.

NCT NCT03269474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03269474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Computational Drug Repurposing for All Epidermolysis Bullosa Simplex (EBS) Cases
Lead sponsor
Joyce Teng
Phase
Observational
Overall status
Unknown status
Start date
November 28, 2017
Completion date
December 31, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolysis bullosa, epidermolysis bullosa dystrophica, epidermolysis bullosa simplex, epidermolysis bullosa, junctional, genetic skin disease, healthy